Elaia doubles down on DeepTech with €134 million DTS3 fund
Paris-based venture capital firm Elaia has closed its third DeepTech seed fund, known as DTS3, at €134 million, marking a significant step up in its commitment to early-stage innovation. The new vehicle is twice the size of the firm’s previous DeepTech seed fund, underlining sustained investor appetite for high‑impact technologies despite a more cautious funding environment.
Fueling Europe’s next generation of DeepTech startups
The new DTS3 fund is designed to back startups at the pre-seed and seed stages that are developing breakthrough technologies in areas such as artificial intelligence, advanced computing, semiconductors, robotics, and climate tech. By targeting science‑driven founders emerging from European universities, research labs, and industrial R&D centers, Elaia aims to help bridge the gap between cutting‑edge research and marketable products.
Strategic focus on high‑impact innovation
With DTS3, Elaia is expected to make dozens of early-stage investments, typically taking the lead in rounds and supporting portfolio companies with hands‑on guidance in go‑to‑market strategy, IP protection, and international expansion. The firm’s strategy leans heavily on long-term value creation, accepting longer development cycles in exchange for defensible technologies and strong barriers to entry.
Sign of resilience in the European VC landscape
The successful closing of a €134 million DeepTech fund stands out at a time when many venture capital firms are facing slower fundraising and more selective limited partners. The size of DTS3, being double that of its predecessor, signals continued confidence in Europe’s capacity to generate globally competitive DeepTech startups.
For founders, the new fund expands the pool of available early-stage capital dedicated specifically to complex, research-heavy technologies. For the wider ecosystem, it reinforces Paris and the broader European market as a growing hub for DeepTech innovation capable of addressing structural challenges in industry, healthcare, and sustainability.